Skip to main content

New Product Watch: May 19, 2009


Illumina this week launched its HumanOmni1-Quad BeadChip [see related article, this issue]. The four-million feature array provides “up-to-date content for all major classes of genetic variation for the study of human disease,” the firm said.
Specifically, the new BeadChip uses tagSNPs from all three phases of the International HapMap Project and offers coverage of known regions of copy-number variation and SNPs of known disease association. Additionally, the HumanOmni1-Quad BeadChip is Illumina’s first product to offer content derived from the 1000 Genomes Project, the company said. The HumanOmni1-Quad BeadChip supports the simultaneous genotyping of four samples. Illumina said the new chips will ship next month.

GeneGo said last week that it has integrated its data-mining system with OmicSoft's visualization and analysis software.

The integration involves GeneGo's MetaCore pathway analysis platform and OmicSoft's Array Studio software, which is used to interpret high-dimensional data.
OmicSoft President Jack Liu said in a statement that the integration will have "an immediate impact for some of our mutual clients, taking the analysis results generated by Array Studio and moving it to the next level with GeneGo's pathway analysis tools."

Users of Array Studio can now access GeneGo's canonical pathway maps in order to enhance their data analysis and hypothesis testing workflow, GeneGo said.

BioMicro Systems last week released new application notes, accessible here, for using its MAUI Hybridization System and MAUI Wash System with several microarray platforms, including those produced by Agilent Technologies, Exiqon, Invitrogen, Phalanx, and Roche NimbleGen, in a variety of applications, such as gene expression, comparative genome hybridization, and microRNA-expression profiling.

The Scan

And For Adolescents

The US Food and Drug Administration has authorized the Pfizer-BioNTech SARS-CoV-2 vaccine for children between the ages of 12 and 15 years old.

Also of Concern to WHO

The Wall Street Journal reports that the World Health Organization has classified the SARS-CoV-2 variant B.1.617 as a "variant of concern."

Test for Them All

The New York Times reports on the development of combined tests for SARS-CoV-2 and other viruses like influenza.

PNAS Papers on Oral Microbiome Evolution, Snake Toxins, Transcription Factor Binding

In PNAS this week: evolution of oral microbiomes among hominids, comparative genomic analysis of snake toxins, and more.